Tasman W, Magargal L E, Augsburger J J
Ophthalmology. 1980 May;87(5):400-2. doi: 10.1016/s0161-6420(80)35225-1.
Of 93 eyes with proliferative diabetic retinopathy treated by argon laser panretinal photocoagulation, two (2.2%) developed rubeosis. The incidence of rubeosis in five xenon-treated eyes was one (1.9%) and in an untreated group of 52 eyes, two (3.8%) developed rubeosis. The incidence of rubeosis in central retinal vein occlusion demonstrating retinal ischemia on fluorescein angiography was 60%, while in patients with central retinal vein occlusion and good capillary perfusion, the incidence of rubeosis only 1%. Panretinal photocoagulation was more effective in controlling rubeosis in diabetics than in patients with central retinal vein occlusion.
在接受氩激光全视网膜光凝治疗的93例增殖性糖尿病视网膜病变患者的93只眼中，有2只眼（2.2%）发生了虹膜新生血管。在接受氙治疗的5只眼中，虹膜新生血管的发生率为1只眼（1.9%）；在未经治疗的52只眼中，有2只眼（3.8%）发生了虹膜新生血管。在荧光素血管造影显示视网膜缺血的视网膜中央静脉阻塞患者中，虹膜新生血管的发生率为60%，而在视网膜中央静脉阻塞且毛细血管灌注良好的患者中，虹膜新生血管的发生率仅为1%。全视网膜光凝在控制糖尿病患者的虹膜新生血管方面比在视网膜中央静脉阻塞患者中更有效。
